Effects of epoxide hydratase inhibitors in forward and reversion bacterial mutagenesis assay systems.
D000818:Animals; D001711:Biotransformation; D003510:Cyclohexanes / Q000494:pharmacology*; D053138:Cyclohexenes; D004851:Epoxide Hydrolases / Q000037:antagonists & inhibitors*; D006843:Hydrocarbons, Chlorinated / Q000494:pharmacology*; D008297:Male; D008862:Microsomes, Liver / Q000378:metabolism; D009152:Mutagenicity Tests; D009153:Mutagens; D051381:Rats; D012486:Salmonella typhimurium / Q000187:drug effects; D014239:Trichloroepoxypropane / Q000494:pharmacology*
D003510:Cyclohexanes; D053138:Cyclohexenes; D006843:Hydrocarbons, Chlorinated; D009153:Mutagens; C007193:cyclohexene oxide; D014239:Trichloroepoxypropane; D004851:Epoxide Hydrolases